microRNA-140-5p from human umbilical cord mesenchymal stem cells-released exosomes suppresses preeclampsia development

This work unraveled the action of human umbilical cord mesenchymal stem cells-released exosomes (huc-MSCs-EXO) transfer of miR-140-5p in preeclampsia (PE). miR-140-5p and follistatin-like 3 (FSTL3) expression in placental tissues of PE patients was tested. EXO were isolated from huc-MSCs. Hypoxic trophoblast cells were co-cultured with huc-MSCs-EXO. Cell biological functions, angiogenesis, and inflammation were evaluated. Suppressed miR-140-5p and induced FSTL3 levels were measured in PE. Huc-MSCs-EXO drove biological functions and angiogenesis while hindering inflammation in hypoxic trophoblast cells. Increasing miR-140-5p further improved the positive role of huc-MSCs-EXO for hypoxic trophoblast cells, but the miR-140-5p-mediated effect in hypoxic trophoblast cells was abrogated by overexpressing FSTL3. miR-140-5p from huc-MSCs-EXO suppresses PE through repressing FSTL3.

Automated summary

This study unraveled the mechanism of action of miR-140-5p transferred by exosomes released from human umbilical cord mesenchymal stem cells (huc-MSCs-EXO) in preeclampsia (PE). It was found that miR-140-5p suppressed PE by repressing FSTL3. Furthermore, huc-MSCs-EXO promoted biological functions and angiogenesis while inhibiting inflammation in hypoxic trophoblast cells.